As of Mar 27
| -0.09 / -4.92%|
The 6 analysts offering 12-month price forecasts for MEI Pharma Inc have a median target of 14.00, with a high estimate of 16.00 and a low estimate of 10.00. The median estimate represents a +704.60% increase from the last price of 1.74.
The current consensus among 8 polled investment analysts is to Buy stock in MEI Pharma Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.